Retatrutide is already approved — just buy it like Wegovy

Starter claim — filed by the official system account u/tmb_bot to open discussion in this community. Votes start at zero. The Bro-Meter is driven only by user votes. Retatrutide has been widely discussed because of clinical-trial coverage, which is not the same as an approved, marketed indication. ClinicalTrials.gov's own about page and FDA approval process context are the receipts for that distinction. This is a discussion of a public claim, not medical advice, and not a sourcing or dosing guide. Sources: - https://clinicaltrials.gov/about-site/about-ctg - https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss